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p190B RhoGAPMicroRNAs (miRNAs) play an important role in various stages of tumor progression. miR-494, which we had pre-
viously identiﬁed as a miRNA induced by ionizing radiation (IR) in the glioma cell line U-251, was observed to en-
hance invasion of U-251 cells by activating MMP-2. The miR-494-induced invasive potential was accompanied by,
and dependent on, epidermal growth factor receptor (EGFR) upregulation and the activation of its downstream sig-
naling constituents, Akt and ERK. The upregulation of EGFR bymiR-494 involved the suppression of lysosomal pro-
tein turnover. Among the putative target proteins tested, p190B RhoGAP (p190B) was downregulated bymiR-494,
and its reduced expression was responsible for the increase in EGFR expression. A reporter assay using a luciferase
construct containing p190B 3′-untranslated region (3′UTR) conﬁrmed that p190B is a direct target of miR-494.
Downregulation of p190B by small interfering RNA (siRNA) transfection closely mimicked the outcomes of miR-
494 transfection, and showed increased EGFR expression, MMP-2 secretion, and invasion. Ectopic expression of
p190B suppressed the miR-494-induced EGFR upregulation and invasion promotion, thereby suggesting that
p190B depletion is critical for the invasion-promoting action of miR-494. Collectively, our results suggest a novel
function for miR-494 and its potential application as a target to control invasiveness in cancer therapy.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The spread of cancer cells into neighboring tissues is termed inva-
sion, and is one of the hallmarks of cancer malignancy. High invasive-
ness is closely related to the aggressiveness and poor prognosis of
tumors. Invasion and metastasis are also closely associated in that can-
cer cells ﬁrst invade connective tissue and penetrate into blood vessels
to initiatemetastasis. Malignant gliomas are typically extremely aggres-
sive tumors that have high invasiveness. Local invasive growth of glio-
mas complicates complete surgical resection, thereby yielding a high
incidence of recurrence with a poor survival rate [1]. In addition to
migratory activity, proteolytic degradation of the extracellular matrix
(ECM) is a critical element of cancer cell invasion, since the ECM is a bar-
rier to invading cancer cells. Cancer cells produce a number of extracel-
lular proteases, such as matrix metalloproteinases (MMPs) and theal growth factor; EGFR, epider-
ivated cell sorting; FBS, fetal bo-
nucleotide exchange factor; IR,
ogen activated protein kinase;
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phosphatidylinositol 3-kinase;
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ights reserved.urokinase-type plasminogen activator (uPA), to degrade ECM compo-
nents and enable penetration into surrounding tissues. Cancer invasion
is controlled by the local microenvironment and involves autocrine and
paracrine factors such as epidermal growth factor (EGF) and transforming
growth factor β (TGFβ), respectively [2,3]. Among the various signaling
components, the members of the receptor tyrosine kinase (RTK) family,
which include epidermal growth factor receptor (EGFR), play a central
role in the regulation of invasion [2,4,5].
The activation of EGFR, which is amember of the HER-erbB family of
RTKs, triggers the activation of various intracellular signaling pathways,
including Ras/mitogen activated protein kinase (MAPK), and phos-
phatidylinositol 3-kinase (PI3K)/Akt pathways, that regulate a variety
of processes such as proliferation, survival, invasion, and metastasis of
cancer cells [6]. EGFR is commonly overexpressed in gliomas and has
been shown to mediate ionizing radiation (IR)-induced MMP-2 secre-
tion and invasion via Akt activation [7]. EGFR signaling is often
hyperactivated in multiple cancer types by several mechanisms such
as activating mutations in the kinase domain, gene ampliﬁcation, and
overexpression of EGFR and its ligands [8–11]. Once activated by the
ligands, EGFR signaling is also regulated by a negative feedback mecha-
nism, which involves endocytosis and subsequent degradation of EGFR
in the lysosome, thereby leading to the termination of receptor signaling
[12]. This process is regulated at various stages bymany proteins includ-
ing a small GTPase, Rab5A, and a guanine nucleotide exchange factor
(GEF) for the Rho family GTPases, Vav2 [13,14]. Importantly, deregula-
tion of this process can lead to abnormal EGFR turnover and signaling.
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coding RNAs of ~22 nucleotides in length, negatively regulate gene ex-
pression at the post-transcriptional level by binding to the 3′-untranslated
region (3′UTR) of target mRNAs [15]. In addition, miRNAs play an impor-
tant role in a variety of biological processes such as proliferation, apopto-
sis, and tumorigenesis [16,17]. The abnormal expression of miRNAs is a
characteristic feature of cancers, and is involved in various stages of tu-
morigenesis [18]. An increasing number of studies have examined the
roles ofmiRNAs in the response of cancer cells to IR,which is an important
genotoxic modality that is widely used for the treatment of cancers.
Notably, a number of miRNAs have been identiﬁed that are regulated by
IR and can modulate sensitivity to radiotherapy [19].
We have recently identiﬁed miR-494 as one of the IR-inducible
miRNAs in the glioma cell line U-251 by using microarray analysis of
the miRNA expression proﬁle [20]. miR-494 did not signiﬁcantly affect
the growth or radiosensitivity of U-251. Here, we report that miR-494
enhances invasion by upregulating EGFR expression and the subsequent
activation of downstream ERK and Akt signaling. Further investigation
revealed that p190B RhoGAP (p190B) was the direct target of miR-
494, the downregulation of which was responsible for EGFR upregula-
tion by miR-494 through protein stabilization. This is a newly identiﬁed
mechanism for regulating EGFR expression during the induction of in-
vasion that could be exploited to develop a novel anti-invasion strategy.
2. Materials and methods
2.1. Cell culture and reagents
The human glioma cell line, U-251, was grown in ME medium sup-
plemented with 10% fetal bovine serum (FBS), penicillin (100 U/mL),
and streptomycin (10 μg/mL) at 37 °C in a humidiﬁed incubator con-
taining 5% CO2. Antibodies against phospho-EGFR (9H2), EGFR (1005),
EGFR (528), p190B (54), SOCS-6 (H-251), Rab5A (S-19), uPA, and β-
actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Phospho-Akt, Akt, phospho-ERK, ERK antibodies were purchased from
Cell Signaling Technology (Beverly, MA), and the MMP-2 antibody
was from Calbiochem (La Jolla, CA). AG1478, LY294002, and PD98059
were also purchased from Calbiochem.
2.2. Plasmid constructs
The expression vector for p190B was constructed by in-frame clon-
ing into the p3XFlag-Myc-CMV vector after PCR ampliﬁcation of the
human p190B open reading frame (ORF) using the primers 5′-CGGC
GGCCGCGATGATGGCAAAAAAC-3′ (forward) and 5′-CCGAATTCTCAT
ATAATGCCAAGAGG-3′ (reverse). The expression vector for the domi-
nant negative (DN, T19N) RhoA was kindly provided by Dr. Park J.B.
(Kangwon National University, Korea). To prepare the reporter con-
structs, DNA fragments of p190B 3′UTRs containing the putative miR-
494 binding sites were cloned into pGL3luc, which was kindly provided
by Dr. Kim (Seoul National University, Korea). The primers for cloning
the p190B 3′UTRs were as follows: p190B 3′UTR-1, 5′-AGTCTAGAGA
AGTGATTGCAAACAGG-3′ (forward) and 5′-AGGAATTCAGTTATCTAC
ACCGACTGC-3′ (reverse); p190B 3′UTR-2, 5′-AGTCTAGATGGTAAGTTA
CTGGAAGG-3′ (forward) and 5′-AGGAATTCAGATTGCGGTTACCTGC-3′
(reverse).Mutant reporter vectors were generated by introducing 3 nu-
cleotide mutations into the putative miR-494 binding sites using a
QuickChange® II Site-Directed mutagenesis kit (Agilent Technologies).
2.3. Oligoribonucleotides and transfection
Synthetic miRNA mimics were synthesized by Samchully Pharma-
ceutical (Seoul, Korea) as RNA duplexes designed from the sequences
of 5′-UGAAACAUACACGGGAAACCUC-3′ (miR-494) and 5′-CUUACGCU
GAGUACUUCGATT-3′ as a negative control of miRNA. An inhibitor of
miR-494 was a 2′-O-methyl-modiﬁed oligoribonucleotide single strandwith a sequence of 5′-GAGGUUUCCCGUGUAUGUUUCATT-3′. Stealth
siRNA duplex oligonucleotides targeting p190B, Rab5A, and EGFR, and
scrambled non-targeting negative control siRNA were purchased from
Santa Cruz Biotechnology. For functional analyses, the cells were
transfected with miRNA or siRNA oligonucletides at a ﬁnal concen-
tration of 20 nM by using G-fectin (Genolution, Seoul, Korea) or
Lipofectamine®RNAiMAX (Invitrogen) according to themanufacturer's
recommendation.
2.4. Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated using a Trizol reagent (Molecular Research
Center Inc.). Two micrograms of RNA was transcribed into single-
stranded cDNA using Superscript II (Invitrogen), and used for PCR am-
pliﬁcation. qRT-PCR was performed using the SYBR premix Ex Taq II
(TaKaRa) and the iCycler real-time PCR detection system (Bio-Rad).
The sequences of the primers were as follows: EGFR, 5′-GGACTCTGGA
TCCCAGAAGGTG-3′ (forward) and 5′-GCTGGCCATCACGTAGGCTT-3′
(reverse); MMP-2, 5′-ACAAAGAGTGGCAGTGCAA-3′ (forward) and 5′-
CACGAGCAAAGGCATCATCC-3′ (reverse); p190B, 5′-AGCCAAATTCCT
GCCAATAAG-3′ (forward) and 5′-AGGAAGGGTGAAAGAATAAGATCCA-
3′ (reverse). qRT-PCR for miRNA quantiﬁcation was performed using
the TaqMan MicroRNA assay kit (Applied Biosystems) and miR-494-
speciﬁc primers according to the manufacturer's instruction. We used
β-actin and U6 spliceosomal RNA as internal normalizers for mRNA
and miRNA, respectively.
2.5. Reporter assay
The cells were transfected with reporter plasmid (100 ng), pRL-
CMV-Renilla plasmid (2 ng), and miRNA using Lipofectamine® 2000
(Invitrogen). After 48 h of transfection, luciferase assays were conduct-
ed using the Dual Luciferase Reporter Assay system (Promega) accord-
ing to the manufacturer's instruction. Fireﬂy luciferase activity was
normalized to Renilla luciferase activity.
2.6. Western blotting
Cell lysates were boiled in sodium dodecyl sulfate (SDS) sample buff-
er, resolved by SDS-polyacrylamide gel electrophoresis (PAGE), and
transferred to nitrocellulose membranes. After the transfer, the mem-
branes were blocked in 5% skim milk in Tris–buffered saline containing
Tween 20 (TBST; 10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.05% Tween
20) for 1 h, and incubated with the speciﬁc primary antibody in 5%
skim milk in TBST for 2 h at room temperature. The membranes were
washed 3 times with TBST and incubated with horseradish peroxidase-
conjugated secondary antibody followed by chemiluminescence detec-
tion using an enhanced chemiluminescence system (ECL; Amersham).
2.7. Wound healing and invasion assay
At 48 h after transfection, the conﬂuent cell monolayer was scratched
across the well using a 200 μL tip and the medium was exchanged with
fresh medium. After incubation for 16 h to allow migration, the cells
were washed twice with PBS, and ﬁxed with 3.7% paraformaldehyde for
30 min followed by staining with 1% crystal violet in 10% ethanol for
30 min. Invasion assays were performed using Transwell® Permeable
Supports (Corning). Cells (2 × 104) in 200 μL of medium were placed
onto the upper surface of Matrigel-coated ﬁlters in Boyden chambers.
The lower chambers were ﬁlled with 1 mL of serum-free medium sup-
plemented with 0.1% BSA. After 20 h of incubation, the cells that hadmi-
grated to the lower surface of the ﬁlter were ﬁxed and stained using a




Fig. 1. IR-inducible miR-494 enhances cell migration, invasion, and MMP2 secretion.
(A) miR-494 expression is induced by IR. Total RNA was extracted from U-251 and
LN428 cells at the indicated times after exposure to IR, and miR-494 expression levels
were quantiﬁed by qRT-PCR. The means of triplicate experiments were plotted and an-
alyzed for statistical signiﬁcance by the Student's t-test. (B) miR-494 enhances migra-
tion and invasion of U-251 cells. The monolayers of the cells transfected with miRNA
were scratched and the cells were stained 16 h after scratching (left panel).
Transfected cells were seeded onto Matrigel-coated inserts in modiﬁed Boyden cham-
bers and processed as described in the Section 2. *, P b 0.001 (N = 3). (C) Determina-
tion of miR-494 level after transient transfection with miR-494. U-251 cells were
transfected with synthesized miR-494 mimic at 20 nM, and total RNA was extracted
at the indicated times after transfection to quantify miR-494 level. (D) miR-494 en-
hances MMP secretion. The abundance of MMP-2, MMP-9, and uPA in the conditioned
medium was determined by Western blot analysis, and the MMP-2 activity was




Fig. 2.miR-494 upregulates EGFR expression and activates EGFR signaling. (A) miR-494
induces upregulation of EGFR protein levels. The cell lysates and total RNA were prepared
from the U-251 cells 48 h after transfection with control or miR-494. The protein and
mRNA levels of EGFR were determined by Western blot and qRT-PCR analysis. miR-494
upregulates EGFR protein levels, but not EGFR mRNA levels. (B) miR-494 upregulates
the abundance of EGFR on the cell surface. The surface EGFR was stained using a FITC-
labeled antibody speciﬁc for the exposed part of EGFR, and the cells were analyzed by
FACS. (C) miR-494 activates EGFR downstream signaling. Transfected cells were serum-
starved for 16 h, then stimulated with EGF (100 ng/mL). The cell lysates were prepared
at the indicated times after EGF treatment and subjected to Western blot analysis.
510 S.-Y. Kwak et al. / Biochimica et Biophysica Acta 1843 (2014) 508–5162.8. Gelatin zymography
The gelatin-digesting activity of themediawas determined to assess
the activity of the MMPs secreted into the media. Cells were incubated
in serum-free media for 24 h to prepare the conditioned media. The
conditioned media were mixed with 2× non-reducing sample buffer
and subjected to 10% SDS-PAGE containing 0.1% gelatin. After electro-
phoresis, the gels were washed in 2.5% Triton X-100 for 1 h, incubated
in gelatinase developing buffer for 16 h at 37 °C, and stained with
0.1% Coomassie brilliant blue. The MMPs activities were visualized as
clear bands against the stained background.
2.9. Determination of EGFR on cell surface
At the indicated times after stimulation with EGF (100 ng/mL), the
cells were harvested in ice cold PBS containing 10% FBS and 1% sodium
azide. The FITC-labeled antibody speciﬁc for surface EGFR (528; Santa
Cruz) was added in the cell suspension, and incubated for 30 min at
4 °C. The cells were washed with cold PBS, resuspended in ice cold
PBS containing 10% FBS and 1% sodium azide, and then analyzed using
a FACS Calibur apparatus (BD Biosciences).
2.10. Determination of RhoA activation
RhoA activation was assessed by RhoA pull-down assays by using a
RhoA activation assay kit (Cell Biolabs, San Diego, CA) according to the
manufacturer's instruction. In brief, Rhoetekin RBD agarose beads
were added to the cell lysates, and incubated at 4 °C for 1 h with gentle
agitation. After thoroughwashing, the proteins bound to the beadswere
eluted in 2× reducing SDS-PAGE sample buffer, and subjected to
Western blot analysis.2.11. Irradiation of cells
Cells were exposed to γ-rays by using a 137Cs γ-ray source (Atomic
Energy of Canada, Ltd., Canada) with a dose rate of 3.81 Gy/min.3. Results
3.1. miR-494 is induced by IR, and enhances cell migration and invasion
In an effort to identify IR-responsive miRNAs using miRNA microar-
ray analysis,we previously identiﬁedmiR-494 as one of the IR-inducible
miRNAs in the glioma cell line U-251 [20]. Here, we measured miR-494
expression at several time points after IR treatment in 2 glioma cell lines
bymiRNA qRT-PCR to validate the previousmicroarray data. Indeed, we
conﬁrmed that IR induced an 8-fold increase in miR-494 expression at
24 h after IR treatment in U-251 cells, while LN428 exhibited a lower
increase of miR-494 expression after IR treatment (Fig. 1A). In the
previous study, analysis of the various IR-linked cellular responses dem-
onstrated that miR-494 does not signiﬁcantly affect cell growth or apo-
ptosis. Based on the report that IR enhances invasion of glioma cells [7],
we decided to examinewhether IR-induciblemiR-494 plays a role in in-
vasive potential. Firstly, we performed wound-healing assays to assess
the effect of miR-494 expression on cellular migratory activity. Trans-
fection with miR-494 enhanced the migration of U-251 cells. The inva-
sion assay using Matrigel-coated transwells showed that miR-494
transfection resulted in markedly increased invasive activity of U-251
cells (Fig. 1B). We checked miR-494 level after transient transfection
with 20 nM miRNA mimic, which is a standard transfection condition
we used for migration and invasion experiments. The qRT-PCR result
showed thatmiR-494 level was increased by several hundred-fold com-
pared to the control (Fig. 1C). We next examined the effect of miR-494
on the expression of extracellular proteases that are known to play an
important role in invasion. Transfection with miR-494 resulted in a
marked increase in MMP-2 secretion with a weak effect on the activa-
tion of MMP-9 and uPA (Fig. 1D). IR alone also caused an increase in
MMP-2 activation as expected from the previous report [7], and the
combined treatment of IR and miR-494 transfection induced an even
greater increase in MMP-2 secretion. The zymograph showing the en-
zyme activity of secreted MMP-2 also conﬁrmed the effect of miR-494
on MMP-2. Taken together, miR-494 efﬁciently activates cellular inva-
sion and the secretion of extracellular proteases, in particular MMP-2.
AB
C
Fig. 3. Enhancement of MMP-2 secretion and invasion bymiR-494 is dependent on EGFR, PI3K/Akt, and ERK activation. (A) Enhancement ofMMP-2 secretion bymiR-494 is dependent on
EGFR. Conditioned media were prepared from the transfected cells after treatment with the EGFR kinase inhibitor AG 1478 (AG, 10 μM) or the cells cotransfected with siRNA speciﬁc for
EGFR (si-EGFR). Western blot analyses were performed to determine theMMP-2 levels in the conditioned media. Densitometric intensities of the bands normalized to that of β-actin are
plotted for better comparison. (B) Enhancement of MMP-2 secretion bymiR-494 is dependent on the downstream signals of the PI3K/Akt and ERK pathways. Transfected cells were treat-
edwith LY294002 (LY, 10 μM), Akt inhibitor I (Akt inh, 10 μM), and PD98059 (PD, 10 μM), and the conditionedmediawere prepared and analyzed for theMMP-2 levels. (C) Promotion of
invasion bymiR-494 is dependent on EGFR, PI3K/Akt, and ERK activation. Cells were pretreatedwith the inhibitors for 2 h before reseeding, andmaintainedwith the inhibitors during the
invasion assays. *, P b 0.001 (N = 3).
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downstream effectors of EGFR signaling
It has been previously reported that IR enhances MMP-2 secretion
and invasion through the EGFR signaling pathway [7]. Therefore, we ex-
amined whether EGFR signaling is involved in the invasion-promoting
action of IR-inducible miR-494. Firstly, we determined the effect of
miR-494 on the expression of EGFR. Transfection with miR-494 in-
creased the protein levels of EGFR, while the mRNA expression of
EGFR was not signiﬁcantly altered by miR-494 (Fig. 2A). This observa-
tion strongly suggests that miR-494 induces the upregulation of EGFR
expression by a posttranscriptional mechanism, such as protein stabili-
zation. Fluorescence-activated cell sorting (FACS) analysis after stainingthe cell surface EGFR showed that the upregulation of EGFR expression
induces increased numbers of the receptor proteins that are exposed on
the cell surface and ready to be activated (Fig. 2B). Next, we examined
the effects of miR-494 on the activation of EGFR and its typical media-
tors of downstream signaling. Compared to the control, phosphoryla-
tion of EGFR in the miR-494-transfected cells was markedly enhanced
and lasted long after stimulation by EGF treatment (Fig. 2C). As expect-
ed from this ﬁnding, ERK activationwas also signiﬁcantly augmented by
transfection with miR-494. The basal Akt phosphorylation level in the
miR-494-transfected cells was higher andmaintained longer after stim-
ulation than in the control. Collectively, these data suggest that EGFR
signaling is a plausible candidatemediator formiR-494 to enhance inva-
sion through MMP-2 activation.
AC
B
Fig. 4.miR-494 upregulates EGFR expression by protein stabilization without affecting ki-
netics of EGFR endocytosis. (A) miR-494 attenuates the turnover of EGFR. The cells
transfected with control or miR-494 were pretreated with cycloheximide (CHX, 20 μg/mL)
for 1 h to block protein synthesis, and then stimulated with EGF (100 ng/mL). The cells
were harvested at the indicated times and analyzed by Western blot. The normalized band
intensitieswere plotted against time after stimulation to determine the kinetics of EGFR deg-
radation. The data were obtained from 3 independent experiments. (B) EGFR upregulation
by miR-494 is mainly through the suppression of lysosomal degradation. The cells
transfected with control or miR-494 were treated with MG-132 (20 μM) or NH4Cl
(200 mM) for 12 h before cell harvesting. Western blot analysis was performed to deter-
mine the EGFR levels. Densitometric intensities of the bands normalized to that of β-actin
are shown. (C) The kinetics of EGFR endocytosis is not affected by miR-494. The cells were
stimulated with EGF (100 ng/mL), and stained for surface EGFR at the indicated intervals.
The ﬂuorescence intensities of the peakswere plotted against time after stimulation. The in-
sert in the upper right shows the plots after the starting level for each is set to 100%.
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dependent on the activation of EGFR, PI3K/Akt, and ERK
To investigate the role of EGFR signaling in the invasion-promoting
action of miR-494, we ﬁrst tested whether inhibition of EGFR signaling
suppresses the miR-494-induced increase in MMP-2 activation. The
treatmentwith AG 1478, which is a speciﬁc inhibitor of EGFR, completely
blocked the miR-494-induced increase in MMP-2 secretion. Knocking-
down EGFR expression by transfection with EGFR-speciﬁc siRNA also ex-
hibited a similar effect (Fig. 3A). Inhibition of Akt activation by treatment
with LY294002 or an Akt inhibitor caused the decrease in basal MMP-2
secretion and also blocked the miR-494-induced increase in MMP-2 se-
cretion (Fig. 3B). Blocking ERK activation by treatmentwith theMEK1 in-
hibitor PD98059 also resulted in signiﬁcant suppression of the MMP-2
secretion enhanced bymiR-494. The effects of the inhibition of EGFR sig-
naling on the action ofmiR-494were also assessed by invasion assay after
treatment with these inhibitors. Similarly to the effect on MMP-2 secre-
tion, inhibiting the activation of EGFR, Akt, and Erk signiﬁcantly sup-
pressed miR-494-induced invasion (Fig. 3C).3.4. miR-494 upregulates EGFR expression by protein stabilization
Our previous observation that miR-494 caused the increase in EGFR
protein levels without altering the mRNA expression (Fig. 2A) suggests
thatmiR-494upregulates EGFR levels by regulating theprotein stability.
Following activation as a result of binding to the ligand EGF, EGFR un-
dergoes endocytosis and subsequent degradation to terminate receptor
signaling. To examine whether miR-494-induced EGFR upregulation is
associated with alterations to the degradation process, we compared
the kinetics of EGFR degradation after stimulation with EGF. In the con-
trol cells, the EGFR levels rapidly decreased to the lowest values (about
20% of the untreated) within 7 min after EGF stimulation. In contrast,
EGFR degradation after EGF stimulation was signiﬁcantly delayed in
the cells transfected with miR-494; more than 50% EGFR remained at
7 min and a higher lowest level wasmaintained (Fig. 4A). This result in-
dicates that miR-494 attenuates the turnover of EGFR. To examine
which proteolytic processes are affected by miR-494, we determined
the EGFR level after miR-494 transfection and treatment with MG-132
and NH4Cl, which are inhibitors of proteasomal and lysosomal protein
degradation, respectively. Treatment with MG-132 caused slightly in-
creased basal EGFR levels, but the EGFR expression in the miR-494-
transfected cells was still signiﬁcantly higher than the control
(Fig. 4B). In contrast, NH4Cl treatment resulted in the enhancement of
the EGFR level of the control to that of the miR-494-transfected cells.
This result strongly suggests that miR-494 induces EGFR upregulation
by interfering mainly with the lysosomal protein degradation pathway.
Next, we determined the kinetics of EGFR internalization after stimula-
tion with EGF by staining EGFR exposed on the cell surface followed by
FACS analysis. After the cells were stimulated with EGF, the distribution
of the cells stained for surface EGFR was shifted toward lower stain in-
tensity, which represents the internalization of EGFR (Fig. 4C). The in-
tensity values of the peaks were plotted against time to compare the
kinetics of EGFR internalization. In both the control and miR-494-
transfected cells stimulated with EGF, the surface EGFR levels quickly
decreased to about 30% of those untreated within 2.5 min, and very
slowly decreased subsequently (Fig. 4C, right). After setting the starting
surface EGFR level of each to 100% (insert), the plots clearly overlapped,
thereby indicating that the kinetics of EGFR internalization were almost
identical. These results suggest thatmiR-494 does not affect EGFR endo-
cytosis, but does inhibit lysosomal degradation of EGFR after activation
by EGF.
3.5. miR-494 upregulates EGFR expression by directly targeting
p190B RhoGAP
To identify the target protein associatedwith the EGFR-stabilizing and
invasion-promoting effects ofmiR-494, we shortlisted the putative target
genes of miR-494 predicted by the miRNA target prediction programs
TargetScan and DIANA-microT 3.0. Various proteins have been reported
to be involved in the regulation of EGFR stability [13,14,21–23]. From
the list of predicted target candidates, we selected 3 proteins that were
expected to have a negative effect on EGFR stability to validate as a target
of miR-494. We ﬁrst determined the expression level of the candidate
proteins after transfection with miR-494 in U-251 and HeLa cells. In
both cell lines, the protein levels of p190B and Rab5A were reduced
when the cells were transfected with miR-494, while the expression of
SOCS-6 was not altered (Fig. 5A). To evaluate whether p190B or Rab5A
is the target protein responsible for the upregulation of EGFR by miR-
494, we next examined the effect of knocking-down the proteins by
siRNA transfection on the expression level of EGFR. Knocking-down
p190B expression resulted in increased EGFR levels, while knocking-
down Rab5A expression did not alter the EGFR expression in either cell
lines (Fig. 5B). Together with the downregulation of p190B expression
by miR-494, the reproduction of EGFR upregulation by knocking-
down p190B strongly suggests that p190B is the target for the EGFR-
upregulating action of miR-494. The mRNA expression level of p190B
AFE G
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Fig. 5.miR-494 upregulates EGFR expression by targeting p190B. (A) miR-494 suppresses the expression of p190B and Rab5A, but not SOCS6. Cells were transfectedwith control or miR-
494, and analyzed for the expression of the selected candidate target proteins. (B) Suppression of p190B expression induces theupregulation of EGFR expression.U-251 andHela cellswere
transfectedwith the siRNAs speciﬁc for p190B (si-p190B) or Rab5A (si-Rab5A), then the cell lysates were prepared 48 h later, and analyzed for EGFR expression. (C) miR-494 reduces the
expression of p190B mRNA. The mRNA levels were determined by conventional RT-PCR (upper) and qRT-PCR (lower) after transfection with miRNA. *, P b 0.005 (N = 3). (D) miR-494
inhibitor exhibits opposite effects ofmiR-494. U-251 cellswere transfectedwith the miR-494 inhibitor and subjected to invasion assay or the cell lysates were prepared after 48 h.
*, P b 0.005 (N = 3). (E) Conﬁrmation of the effects of miR-494 in LN428. LN428 cells were transfected with miR-494 and incubated for 48 h. The procedure was the same to
that for U-251. *, P b 0.005 (N = 3). (F) Structures of reporter constructs containing p190B 3′UTRs downstream of the luciferase ORF. The aligned sequences of p190B 3′UTRs comple-
mentary to the seed sequence of the miR-494 seed sequence and the mutant sequences are shown. The mutated regions are shaded. (G) Reporter assay showing the direct targeting
of p190B 3′UTR by miR-494. U-251 cells were transfected with a combination of the indicated reporters and miRNAs, and the dual-luciferase assay was performed 48 h later. Fireﬂy
luciferase activity was normalized to Renilla luciferase activity. The data were obtained from 3 independent experiments. *, P b 0.05; **, P b 0.005; ***, P b 0.001 (n = 6).
513S.-Y. Kwak et al. / Biochimica et Biophysica Acta 1843 (2014) 508–516was also reduced by transfectionwithmiR-494 (Fig. 5C). In contrast, in-
hibition of endogenous miR-494 using miR-494 inhibitor (α-miR-494)
exhibited opposite effects of miR-494; downregulation of MMP2 secre-
tion, reduction of EGFR expression and increase of p190B protein levels.
The invasion ability of the cells was also decreased (Fig. 5D). We also
conﬁrmed the effect ofmiR-494 on p190B/EGFR/invasion axis using an-
other glioma cell line, LN428. miR-494 led to the increase in MMP2
secretion, EGFR protein levels and invasion ability, as well as the sup-
pression of p190B expression (Fig. 5E). Next, we tested whether
p190B is a direct target of miR-494 by reporter assay. Four putative
miRNA regulatory elements for miR-494 were found in the 3′UTR of
p190B mRNA. To determine whether miR-494 directly targets these el-
ements, we cloned 2 3′UTR fragments containing 2 miRNA regulatory
elements each into the modiﬁed pGL3 reporter vector downstream of
the ﬁreﬂy luciferase ORF (Fig. 5F). The 2 reporters were co-transfected
into U-251 cells togetherwith the control ormiR-494, and the luciferase
activity was measured 2 days after transfection. miR-494 strongly re-
duced the relative luciferase activity of the p190B-1 reporter to below
50% of the control, but not the p190B-2 reporter, thereby indicating
that only p190B 3′UTR-1, which is located closer to the stop codon of
p190B mRNA, is targeted by miR-494 (Fig. 5G). For further validation
for the speciﬁcity and response of each miRNA regulatory element in
targeting the p190B 3′UTR-1 by miR-494, mutant reporters containing
a 3-nucleotide mutation introduced into each miRNA regulatory ele-
ment were also prepared. The single mutations in each miRNAregulatory element partially suppressed the reduction of luciferase ac-
tivity by miR-494, and the double mutation in both miRNA regulatory
elements completely abolished the response to miR-494. These results
together conﬁrm that p190B is a direct target of miR-494 and 2
miRNA regulatory elements located between 56 and 90 bpdownstream
of the stop codon are the target sequences to which miR-494 binds.
3.6. Invasion-promoting action of miR-494 is mediated by p190B
downregulation independently of RhoA activation
Having shown that miR-494 directly targets p190B and induces
EGFR upregulation,we examinedwhether the suppression of p190B ex-
pression stabilizes EGFR like miR-494 does. Knocking down p190B ex-
pression by siRNA transfection delayed the turnover of EGFR after the
stimulation with EGF (Fig. 6A), suggesting that miR-494-meidated
p190B downregulation is responsible for the upregulation of EGFR by
miR-494 through protein stabilization. Next, we tried to analyze the
role of p190B downregulation in the promotion of invasion by miR-
494. Downregulation of p190B expression by siRNA transfection result-
ed in increased MMP-2 secretion and invasion (Fig. 6B, C), which mim-
icked the effect of miR-494. To further conﬁrm that miR-494 induces
invasion mainly by targeting p190B, we tested whether the reconstitu-
tion of p190B expression by co-transfection with the Flag-p190B ex-
pression vector could suppress the invasion-promoting action of miR-





Fig. 6.Downregulation of p190B is essential for miR-494-promoted invasion independent of the regulation of RhoA activity. (A) Knocking-down p190B expression delays the turnover of
EGFR. The cells transfectedwith control or si-p190Bwere pretreatedwith cycloheximide (CHX, 20 μg/mL) for 1 h, and then stimulatedwith EGF (100 ng/mL). The cells were harvested at
the indicated times and analyzed for EGFR level byWestern blotting. (B) Knocking-down p190B expression enhancesMMP-2 secretion accompanied by the increase of EGFR expression.
(C) Knocking-down p190B expression promotes the invasion of U-251 cells. *, P b 0.001 (N = 3). (D) Reconstitution of p190B expression suppresses MMP-2 secretion and EGFR upreg-
ulation induced by miR-494. U-251 cells were transfected with a combination of miR-494 and Flag-p190B expression vector. The conditioned media and cell lysates were prepared 48 h
later and used to determine the MMP-2 and EGFR levels by using Western blot analysis. (E) Reconstitution of p190B expression suppresses the invasiveness of U-251 cells promoted by
miR-494. U-251 cells transfected with a combination of miR-494 and Flag-p190B expression vectors were seeded onto Matrigel-coated ﬁlters to perform the invasion assay. *, P b 0.001
(N = 3). (F) Downregulation of p190B bymiR-494 does not lead to RhoA activation. The cell lysateswere prepared fromU-251 cells transfectedwith control ormiR-494, and subjected to
RhoA pull down assays using recombinant Rhoetekin RBD agarose beads. The RhoA pulled down by the beadswas analyzed byWestern blotting. The cell lysate prepared from the GTPγS-
treated cells was included as a positive control. (G) Dominant negative mutant of RhoA does not affect MMP-2 secretion and EGFR upregulation induced by miR-494. U-251 cells were
transfected with a combination of miR-494 and the expression vector for dominant negative (T19N) RhoA, and the conditioned media and cell lysates were prepared for Western blot
analysis.
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sion (Fig. 6D). The invasion assay also showed that Flag-p190B expres-
sion signiﬁcantly suppressed miR-494-induced invasion (Fig. 6E).
Together, these results strongly suggest that p190B downregulation is
a critical step in the invasion promoted by miR-494. Since p190B has
an activity to enhance returning of active GTP-bound Rho GTPases to
the basal inactive GDP-bound state, we tested whether the action of
miR-494 through downregulation of p190B involves RhoA activation.
Contrary to expectations, transfection with miR-494 did not result in
the activation of RhoA (Fig. 6F). Accordingly, the upregulation of EGFR
andMMP-2 secretion induced bymiR-494 expressionwere not affected
by overexpression of dominant negativemutant RhoA (Fig. 6G), thereby
suggesting that the negative regulation of EGFR by p190B is achieved in-
dependently of the catalytic activity as a RhoGAP to inactivate RhoA.
4. Discussion
Growing evidence suggests that aberrantmiRNA expression is close-
ly linked to various types of cancer, and numerous miRNAs play impor-
tant roles in various processes related to cancer biology, such asapoptosis and neoplastic transformation [16,24]. In this study, we identi-
ﬁedmiR-494 as an IR-induciblemiRNA that promotes invasion by upreg-
ulation of EGFR expression and subsequent activation of downstream
ERK and Akt signaling in glioma cell lines. We further demonstrated
that p190B is the direct target of miR-494, downregulation of which is
responsible for the EGFR upregulation by miR-494 through protein
stabilization.
Many groups have reported a variety of miRNAs having invasion-
suppressing or -promoting functions. Recent studies have demonstrat-
ed that many miRNAs such as miR-107, miR-383, miR-134, miR-15b,
miR-152, and miR-146b-5p inhibit the invasion of various cancer cells
by directly targeting the signaling molecules such as Notch2, IGFR1,
Nanog, neuropilin2, MMP-3, and EGFR, respectively [25–29]. Compara-
tively, several invasion-promoting miRNAs have also been reported.
Speciﬁcally, miR-92b and miR-24 promote the proliferation and inva-
sion of glioma through the regulation of Wnt/β-catenin signaling via
targeting Nemo-like kinase (NLK) and suppression of tumorigenicity
7-like (ST7L), respectively [30,31].miR-10b induces glioma cell invasion
by regulating MMP-14 and uPAR expression via the direct targeting of
HOXD10 [32]. Unlike these miRNAs, miR-494 was demonstrated to
Fig. 7. Schematic summary for the invasion-promoting action of IR-inducible miR-494
through EGFR upregulation by directly targeting p190B in glioma cells.
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EGFR expression in our study.
The upregulation of EGFR expression is often associated with carci-
nogenesis, and the resistance to tumor treatment, and can be achieved
by multiple mechanisms. Ampliﬁcation of the EGFR gene located on
chromosome 7 is also a common genetic feature of gliomas and is
known to be associated with shorter survival in patients who
underwent a variety of treatments [33,34]. The U-251 cell line is also
known to harbor EGFR gene ampliﬁcation [35]. Our data indicates that
miR-494 can lead to further upregulation of EGFR expression by protein
stabilization even in a U-251 cell line that already expresses a high level
of EGFR due to gene ampliﬁcation. On the other hand, the miR-494 in-
hibitor reduced EGFR levels and invasion in U-251 cells, suggesting
that targeting miR-494 can be a good strategy to control invasiveness
of gliomas that commonly harbor EGFR ampliﬁcation.
Besides gene ampliﬁcation or transcriptional induction of EGFR,
EGFR abundance at the cell surface can be regulated by various mecha-
nisms atmultiple stages. After EGFR activation by ligand binding, theCbl
protein mediates initial ubiquitination of EGFR, which targets it for en-
docytosis [36], and a variety of proteins including endosomal Rab pro-
teins, Mig6, and Vav2 are known to regulate the trafﬁcking from early
endosomes to lysosomes and the subsequent degradation of EGFR
[13,14,37,38]. Vav2, a GEF for Rho GTPases, positively regulates the sta-
bility of EGFR by delaying the internalization and degradation of EGFR
[14]. Since p190B is a RhoGAP that plays an opposite role to Vav2 in
the regulation of Rho activity, we analyzed whether p190B is a direct
target of miR-494 and involved in the EGFR stabilization and invasion
promotion bymiR-494. Our results showed that p190B is the direct tar-
get of miR-494 and the downregulation of p190B is the main mecha-
nism used by miR-494 to upregulate EGFR and promote glioma cell
invasion. However, EGFR upregulation by miR-494 differed from thatby the action of Vav2. In our results, miR-494 did not affect the kinetics
of EGFR internalization and seemed to mainly suppress the lysosomal
degradation of EGFR, which is in contrast to the case of Vav2 overex-
pression that delays both internalization and degradation of EGFR.
EGFR stabilization through p190B downregulation by miR-494 was
not accompanied by RhoA activation in our study using U-251 cells,
while it was shown that RhoA is necessary for Vav2-mediated EGFR sta-
bilization in HeLa cells. Several contradictory reports suggest that the
function and mechanism of the major RhoA regulator p190 RhoGAP
can vary depending on the cellular context and the processes involved.
A study has demonstrated that p190 RhoGAP reduces pancreatic cancer
cell invasion and metastasis by inactivating Rho GTPases [21]. In con-
trast, p190B was shown to have pro-tumorigenic functions during
MMTV-Neu-inducedmammary tumor formation andmetastasis by en-
hancing cell adhesion and invasion through a Rac1/ROS dependent
mechanism [39]. During matrix remodeling and angiogenesis, p190B
mediates the expression of MMP-2 and MT1-MMP in endothelial cells
independently of RhoA activation [40]. This is in contrast to our result
that p190B downregulation enhances MMP-2 secretion in U-251 cells.
It is possible that in U-251 cells, EGFR accumulation by miR-494-
mediated p190B downregulationmay dominate the otherwise opposite
effects of p190B downregulation, consequently leading to the enhance-
ment of MMP-2 activation and invasion. The mechanism of how p190B
regulates the stability of EGFR independently of RhoA inactivation re-
mains to be elucidated.
While this studywas underway, several reports on the various func-
tions of miR-494 have been published. miR-494 exerts cardioprotective
effects against ischemia/reperfusion-induced injury, although both
proapoptotic proteins (PTEN, ROCK1 andCaMKI) and antiapoptotic pro-
teins (FGFR2 and LIF) are targeted by miR-494 [41]. miR-494 is regulat-
ed by ERK1/2 and induces TRAIL resistance in non-small-cell lung
cancer through downregulation of BIM [42]. TGFβ1-induced miR-494
plays a key role in the accumulation and functions of myeloid-derived
suppressor cells, which support tumor angiogenesis and metastasis,
via targeting PTEN [43]. While these studies can be regarded to have
demonstrated the cytoprotective or oncogenic characteristics of miR-
494, there are also contrasting reports that demonstrate miR-494 is a
tumor suppressor. miR-494 plays a suppressive role in IR-induced an-
giogenesis, which is associated with the MMP-9-miR-494-syndecan-1
regulatory loop in medulloblastoma cells [44]. In cholangiocarcinoma
cells,miR-494 induces G2/Marrest by targetingmany proteins involved
in theG2/M transition such as CDC2, CDC20, and cyclin B1 [45].miR-494
inhibits the cell proliferation of gastrointestinal stromal tumor by
targeting KIT expression [46]. It is not uncommon that a miRNA plays
opposite roles depending on the cellular context, because a single
miRNA can simultaneously regulate amultitude of different speciﬁc tar-
get proteins. Likewise, the research implies that miR-494 has ambiva-
lent functions. Glioma cells were not included in the list of cellular
contexts in these previous studies analyzing the various functions of
miR-494. In our study, the proliferation or cell cycle of U-251 glioma
cells were not signiﬁcantly affected by miR-494, but the effect of miR-
494 on invasion through EGFR upregulationwas signiﬁcantly promotive
in the U-251 cells. This suggests that aiding the promotion of invasion
may be amain function ofmiR-494 in gliomas. Considering the previous
report that glioma invasion is enhanced by IR through EGFR upregula-
tion [7], the induction of miR-494 expression may be a key step in the
promotion of glioma invasion by IR. Therefore, miR-494 is an attractive
candidate target to control metastasis after radiotherapy against brain
tumor.
In this study, we revealed a novelmiR-494-mediatedmechanism in-
volved in the upregulation of EGFR expression and induction of invasion
that entails the direct targeting of p190B and the subsequent stabiliza-
tion of EGFR (Fig. 7). This is a new mechanism for regulating EGFR ex-
pression during the induction of invasion. Our ﬁndings will help
develop a strategy to counteract the high invasiveness of glioma during
cancer treatments like radiotherapy.
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